SciELO - Scientific Electronic Library Online

 
vol.81 número2Controversias durante la pandemia de COVID-19Consenso Argentino de toxoplasmosis congénita 2020 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Medicina (Buenos Aires)

versión impresa ISSN 0025-7680versión On-line ISSN 1669-9106

Resumen

RIDRUEJO, Ezequiel; MENDIZABAL, Manuel  y  SILVA, Marcelo O.. Simplified treatment of hepatitis C: another strategy to overcome the barriers to its elimination. Medicina (B. Aires) [online]. 2021, vol.81, n.2, pp.252-256. ISSN 0025-7680.

The clinical management of hepatitis C virus (HCV) infection presents several challenges today. WHO’s goal is to eliminate it by 2030. It is an ambitious goal and difficult to meet given the barriers to care that arise. This is possible today thanks to the discovery of direct-acting antivirals (DAAs). This treatment achieves a high cure rate and is virtually free of adverse effects. To try to comply with this, in addition to the use of DAAs, it is necessary to reduce the rate of undiagnosed patients and facilitate the access of those diagnosed to care and treatment. For that, it is proposed to carry out a simplified treatment of HCV. This involves reducing controls during and after treatment. This simplification varies according to whether patients have cirrhosis or not. In this way, it seeks to increase significantly the number of patients treated and cured to reduce the burden on public health of this disease.

Palabras clave : Direct-acting antivirals; Treatment; Elimination; Hepatitis C.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )